Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01769209
Title Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University
Indications

acute lymphoblastic leukemia

Therapies

Bortezomib

Cytarabine + Methotrexate

Dexamethasone + Doxorubicin + Pegaspargase + Vincristine Sulfate

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University, School of Medicine Stanford California 94305 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field